Found: 17
Select item for more details and to access through your institution.
Analysis of MET Genetic Aberrations in Patients With Breast Cancer at MD Anderson Phase I Unit.
- Published in:
- Clinical Breast Cancer, 2014, v. 14, n. 6, p. 468, doi. 10.1016/j.clbc.2014.06.001
- By:
- Publication type:
- Article
Long-term overall survival and prognostic score predicting survival: the IMPACT study in precision medicine.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. 1, doi. 10.1186/s13045-019-0835-1
- By:
- Publication type:
- Article
A phase 2, open-label study of brentuximab vedotin in patients with CD30-expressing solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 738, doi. 10.1007/s10637-019-00768-6
- By:
- Publication type:
- Article
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 6, p. 1016, doi. 10.1007/s10637-018-0591-z
- By:
- Publication type:
- Article
<i>FBXW7</i> Mutations in Patients with Advanced Cancers: Clinical and Molecular Characteristics and Outcomes with mTOR Inhibitors.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089388
- By:
- Publication type:
- Article
Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Association between new-onset hypothyroidism and clinical response in patients treated with tyrosine kinase inhibitor therapy in phase I clinical trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I clinical trial of lenalidomide in combination with bevacizumab in patients with advanced cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Outcomes of patients ≥65 years old with advanced cancer treated on phase I trials at MD ANDERSON CANCER CENTER.
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 1, p. 208, doi. 10.1002/ijc.30417
- By:
- Publication type:
- Article
Dual inhibition of the vascular endothelial growth factor pathway: A phase 1 trial evaluating bevacizumab and AZD2171 (cediranib) in patients with advanced solid tumors.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 14, p. 2164, doi. 10.1002/cncr.28701
- By:
- Publication type:
- Article
Prevalence of complementary medicine use in a phase 1 clinical trials program.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 22, p. 5142, doi. 10.1002/cncr.26164
- By:
- Publication type:
- Article
Barriers to Study Enrollment in Patients With Advanced Cancer Referred to a Phase I Clinical Trials Unit.
- Published in:
- Oncologist, 2013, v. 18, n. 12, p. 1316, doi. 10.1634/theoncologist.2013-0202
- By:
- Publication type:
- Article
A pilot study of temsirolimus and body composition.
- Published in:
- Journal of Cachexia, Sarcopenia & Muscle, 2013, v. 4, n. 4, p. 259, doi. 10.1007/s13539-013-0113-y
- By:
- Publication type:
- Article
Multiple gene aberrations and breast cancer: lessons from super-responders.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1439-y
- By:
- Publication type:
- Article
Multiple gene aberrations and breast cancer: lessons from super-responders.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 442, doi. 10.1186/s12885-015-1439-y
- By:
- Publication type:
- Article
Multiple gene aberrations and breast cancer: lessons from super-responders.
- Published in:
- 2015
- By:
- Publication type:
- journal article